FDA Approval Activities for this Drug… NIMOTOP (nimodipine) Capsules,30 mg, Bayer Pharmaceutical Division NDA 18-869/S10 8/22/00 8/23/00 8/23/00 NIMOTOP (nimodipine) Capsules,Rx Bayer Pharmaceutical Division NDA 18-869 8/22/00 Nimotop Indications: for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranialberry aneurysms regardless of their post-ictus neurologic condition. Back to this API's Main Page.

Browse other API's patent/exclusivity pages… A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Find API by Brand Name | Industry Information | Prescription Drug Websites | Search | Site Map         © 2008 Betterchem Corp.